Boutique Biotech

Boutique Biotech

Share this post

Boutique Biotech
Boutique Biotech
Affimed update

Affimed update

ASH22 Preliminary Data and Artiva the NK Source Commercial Partner

Bohdan (Bo) Khomtchouk, Ph.D.'s avatar
Bohdan (Bo) Khomtchouk, Ph.D.
Nov 05, 2022
∙ Paid

Share this post

Boutique Biotech
Boutique Biotech
Affimed update
Share

Affimed ($AFMD) announced an early look at updated AFM13+NK data that will be presented at the ASH conference on December 10, 2022. The data was strong. Importantly, Affimed also announced Artiva as their commercial NK-source partner. The stock has traded up more than 10% to over $2/share.

ASH22 Preliminary Data
From the last update in April 2022 until t…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Bohdan (Bo) Khomtchouk, Ph.D.
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share